Vaping for weight control: Findings from a qualitative study.
E-cigarettes
Qualitative research
Vaping
Weight control
Weight loss
Journal
Addictive behaviors reports
ISSN: 2352-8532
Titre abrégé: Addict Behav Rep
Pays: Netherlands
ID NLM: 101656077
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
15
01
2020
revised:
11
04
2020
accepted:
15
04
2020
entrez:
9
7
2020
pubmed:
9
7
2020
medline:
9
7
2020
Statut:
epublish
Résumé
Smokers have expressed concern about weight gain once they stop smoking and weight gain is a risk factor associated with smoking relapse. Nicotine in e-cigarettes, as well as vaping behaviour, may support smoking cessation by reducing weight gain. This study explored the factors that influence attitudes towards, and awareness of, e-cigarettes and weight control post smoking cessation. Qualitative study involving focus groups with adults in the UK (n = 58) who were either exclusive vapers or dual users. There was limited awareness and/or inclination to vape to prevent weight gain after stopping smoking. Reasons for this centred on: the health gains of stopping smoking outweighing any potential weight gain; a lack of understanding of the appetite supressing effects of nicotine; a belief that vaping could not suppress appetite like a cigarette and could result in craving for certain flavours; concerns about the longer-term effects of e-cigarettes on health and the ethics of promoting vaping as way to support smoking cessation by limiting weight gain, especially for young women. Participants in this study do not appear inclined to use e-cigarettes to prevent weight gain after smoking cessation. There is a lack of understanding about why nicotine might help prevent weight gain and a concern that e-cigarette flavours could provoke cravings and that vaping may be unsafe in the long-term.
Identifiants
pubmed: 32637557
doi: 10.1016/j.abrep.2020.100275
pii: S2352-8532(20)30012-2
pii: 100275
pmc: PMC7330875
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100275Informations de copyright
© 2020 The Authors.
Déclaration de conflit d'intérêts
JB has received unrestricted research funding relating to smoking cessation from Pfizer, who manufacture smoking cessation medications. All authors declare no financial links with tobacco companies or e-cigarette manufacturers or their representatives.
Références
J Community Health. 2019 Dec;44(6):1120-1126
pubmed: 31273619
Am J Public Health. 1992 Jun;82(6):799-803
pubmed: 1585959
Addiction. 2016 Jun;111(6):1118-9
pubmed: 26920514
Addict Behav. 2019 Aug;95:211-219
pubmed: 30981033
Eat Weight Disord. 2020 Apr;25(2):487-495
pubmed: 30554326
BMJ. 2012 Jul 10;345:e4439
pubmed: 22782848
Addict Behav. 2015 Feb;41:29-33
pubmed: 25290526
Nicotine Tob Res. 2017 Nov 7;19(12):1536-1540
pubmed: 27798086
Sci Rep. 2016 Jan 05;6:18763
pubmed: 26729619
Int J Eat Disord. 2018 Jan;51(1):77-81
pubmed: 29076176
J Adolesc Health. 2003 Apr;32(4):306-13
pubmed: 12667735
Am J Prev Med. 2015 Jan;48(1 Suppl 1):S61-4
pubmed: 25528710
Addiction. 2011 Jan;106(1):188-96
pubmed: 20925685
Addict Behav. 1998 Sep-Oct;23(5):609-22
pubmed: 9768298
Addict Behav Rep. 2018 Dec 07;9:100151
pubmed: 31193745
Acad Med. 2014 Sep;89(9):1245-51
pubmed: 24979285
Addiction. 2019 May;114(5):879-888
pubmed: 30609154
Drug Alcohol Rev. 2018 Sep;37(6):810-817
pubmed: 29920819
Addict Behav. 2016 Jan;52:91-7
pubmed: 26406973
Addict Behav. 2015 Oct;49:20-5
pubmed: 26036665
Nutr Rev. 2011 Dec;69(12):745-53
pubmed: 22133198
Int J Epidemiol. 2011 Dec;40(6):1617-28
pubmed: 21593077
Int J Epidemiol. 2015 Apr;44(2):540-50
pubmed: 25777141
Tob Regul Sci. 2017 Jan;3(1):108-114
pubmed: 28653023